Showing results (1601-1610 of 1,739) with videos related to

Sort By:
Pageof 174
Nature Protocols|February 10, 2025
Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomicsA K L Wezenaar, U Pandey, F Keramati, et al.
Science Advances|April 6, 2022
Hypothyroidism confers tolerance to cerebral malariaDiego Rodriguez-Muñoz, Ángela Sánchez, Susana Pérez-Benavente, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 14, 2023
Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch SyndromeJúlia Canet-Hermida, Fátima Marín, Eduard Dorca, et al.
International Journal of Cancer|February 14, 2025
Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndromePaula Peremiquel-Trillas, José Manuel Martínez, Sònia Paytubi, et al.
Bjpsych International|July 21, 2021
Child and adolescent psychiatry training curriculum: a global trainee's perspectiveSundar Gnanavel, Pawan Sharma, Antonin Sebela, et al.
Oncotarget|October 15, 2014
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growthJuan Huertas-Martínez, Santiago Rello-Varona, David Herrero-Martín, et al.
Environment International|September 19, 2021
Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individualsSilvia Alemany, Marta Crous-Bou, Natalia Vilor-Tejedor, et al.
Open Forum Infectious Diseases|December 15, 2025
Epidemiology and Outcomes of Pediatric Fever in a Rural District of Southern Mozambique: 17 Years of Morbidity SurveillanceDavid Torres-Fernandez, Jessica Dalsuco, Cristina Garcia-Mauriño, et al.
Head & Neck|August 16, 2019
Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primaryPaolo Boscolo-Rizzo, Lea Schroeder, Valeria Sacchetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapyMaria Jove, Irene Braña, Marc Oliva, et al.
Pageof 174